Cell Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.01.25	Forecasting The Future: 6 Analyst Projections For Lineage Cell Therapeutics (Benzinga)
03.01.25	The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 Experts (Benzinga)
07.03.24	Lineage Cell Therapeutics: Q4 Earnings Insights (Benzinga)
15.05.18	Zodiac's Craig Goodson Joins UAG (PR Newswire)
31.01.18	Startup Food Company Unveils New Snack Line in Los Angeles (PR Newswire)
29.11.17	AtScale furthers vision, brings its Universal Semantic Layer to the AWS Cloud (PR Newswire)
26.07.17	Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital (PR Newswire)
03.05.17	Amplero Expands Artificial Intelligence Marketing Platform for Scalable, Intelligent, and Personalized Cross Channel Marketing (PR Newswire)
08.02.17	CTI BioPharma to Present at the BIO CEO & Investor Conference (PR Newswire)
24.01.17	CTI Biopharma Appoints Leading BioPharma Executive Michael Metzger to board of directors (PR Newswire)
17.01.17	Technical Reports on Biotech Stocks -- ContraVir Pharma, Arena Pharma, Neuralstem, and CTI BioPharma (PR Newswire)
09.01.17	CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017 (PR Newswire)
05.01.17	CTI BioPharma Announces Removal Of Full Clinical Hold On Pacritinib (PR Newswire)
06.12.16	PERSIST-2 Phase 3 Study Of Pacritinib Versus Best Available Therapy Shows Encouraging Clinical Activity In High-Risk Patients With Advanced Myelofibrosis In Late-Breaking Session At ASH Annual Meeting (PR Newswire)
01.12.16	CTI BioPharma Presents Nonclinical Pharmacology Study Demonstrating Pacritinib Has Distinct Profile Amongst JAK Inhibitors At EORTC-NCI-AACR Molecular Targets And Cancer Therapeutics Symposium (PR Newswire)
22.11.16	Biotech Stocks on Investors' Radar -- Vertex Pharma, Nektar Therapeutics, CTI BioPharma, and Sage Therapeutics (PR Newswire)
01.10.15	CTI BioPharma, Fred Hutch Establish $1.5 Mln Endowment Fund For Cancer Research (RTTNews)
27.07.15	CTI BioPharma Names Bruce Seeley EVP, Chief Commercial Officer (RTTNews)
10.06.15	CTI BioPharma Amends Existing Loan Agreement With Hercules Technology Growth (RTTNews)
10.06.15	CTI BioPharma, Baxter Announce PROs From Pacritinib Phase 3 In Myelofibrosis (RTTNews)
10.03.15	ACRX Plunges On Zalviso News, CTIC Persists, HTBX On Fire, PIP Cuts Head Count (RTTNews)
03.02.15	CTI BioPharma: Independent DMC Urges Continuing GOG-0212 Phase 3 Trial Of OPAXIO (RTTNews)
12.01.15	CTI BioPharma Names Alan Burnett Therapeutic Area Lead, Myeloid Diseases (RTTNews)
04.12.14	CTI BioPharma Receives Milestone Payment For TRISENOX - Quick Facts (RTTNews)
27.10.14	CTI Buys Exclusive Worldwide Rights To Tosedostat - Quick Facts (RTTNews)
04.03.14	Cell Therapeutics Posts Q4 Profit (RTTNews)
28.01.14	CTI: GOG Completes Patient Enrollment In GOG-0212 Phase 3 Study Of Opaxio (RTTNews)
04.12.13	Cell Therapeutics, GKV-SV Reach Agreement On Pixuvri Pricing In Germany (RTTNews)
21.10.13	Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
21.10.13	Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting (PR Newswire)
15.10.13	Cell Therapeutics: NICE Issues Second Draft Guidance On PIXUVRI - Quick Facts (RTTNews)
15.10.13	Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) (PR Newswire)
10.10.13	Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda (PR Newswire)
07.10.13	Cell Therapeutics Announces Agreement with the FDA on Special Protocol Assessment for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis (PR Newswire)
25.09.13	Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. (PR Newswire)
19.09.13	Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock (PR Newswire)
19.08.13	Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. (PR Newswire)
19.08.13	Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) (PR Newswire)
24.07.13	Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics' Scientific Advisory Board (PR Newswire)
24.07.13	Cell Therapeutics to Report Second Quarter Financial Results after Market on July 31, 2013 (PR Newswire)
02.10.12	Cell Therapeutics: Orphan Drug Status erhalten (Aktiencheck)
18.03.08	Wall Street Media Presents a Video of Dr. James Bianco, CEO of Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (Businesswire)
11.03.05	Börse Stuttgart-Kolumne: Marktbericht Auslandsaktien (KW 10) (n/a)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cell Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten